Comparing hospital and telephone follow up for women treated for endometrial cancer (ENDCAT): ENDometrial CAncer Telephone follow up trial)

Phase 3

Completed

• Conditions: Topic: National Cancer Research Network; Subtopic: Gynaecological Cancer; Disease: Endometrium; Cancer; Malignant neoplasm of Endometrium

• Registration Number: ISRCTN75220876
• Lead Sponsor: ancashire Teaching Hospitals NHS Trust (UK)

Brief Summary

2018 Results article in https://www.ncbi.nlm.nih.gov/pubmed/29651778 results

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2011-10-28
• Study Completion: 2014-06-30
• Last Update Posted: 7 November 2022

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 259

Inclusion Criteria

1. Known diagnosis of Stage I endometrial cancer
2. Completed primary treatment (e.g. surgery, radiotherapy, chemotherapy)
3. Attending outpatient clinics for the purposes of routine monitoring and surveillance
4. Access to a telephone
5. No age limitations
Gender = female; Target Gender: Female

Exclusion Criteria

1. Known diagnosis of stage II, III or IV endometrial cancer
2. Currently receiving active treatment
3. Taking part in clinical trials that have pre-defined follow-up regimes
4. Auditory problems that inhibit the use of the telephone
5. Cannot speak or understand English where no interpreter services are available

Study & Design

• Study Type: Interventional
• Study Design: Not specified